Wanda Roberton, MD in Federal Way, WA - General Practice

Wanda Roberton, MD is a General Practice physician based in Federal Way, Washington. Wanda Roberton is licensed to practice in Washington (license number MD00018181) and her current practice location is 32020 1st Ave S, Suite 115, Federal Way, Washington. She can be reached at her office (for appointments etc.) via phone at (253) 838-6556.

NPI number for Wanda Roberton is 1730272147 and her current mailing address is 32020 1st Ave S, Suite 115, Federal Way, Washington. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1730272147.

Contact Information

	Wanda Roberton, MD
	32020 1st Ave S, Suite 115, Federal Way, WA 98003-5717
	(253) 838-6556
	(253) 661-4523

Physician's Profile

Full Name	Wanda Roberton
Gender	Female
Speciality	General Practice
Location	32020 1st Ave S, Federal Way, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1730272147
Provider Enumeration Date: 09/30/2006
Last Update Date: 07/09/2007

Medical Identifiers

Medical identifiers for Wanda Roberton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1730272147	NPI	-	NPPES
RA98	Other	WA	REGENCE RIDER NUMBER

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	MD00018181 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Wanda Roberton is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Wanda Roberton, MD 32020 1st Ave S, Suite 115, Federal Way, WA 98003-5717 Ph: (253) 838-6556	Wanda Roberton, MD 32020 1st Ave S, Suite 115, Federal Way, WA 98003-5717 Ph: (253) 838-6556

News Archive

Biovex announces OncoVEXGM-CSF Phase 3 study for head and neck cancer

BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced today that a Phase 3 pivotal study with OncoVEXGM-CSF for the first line treatment of patients with locally advanced squamous cell carcinoma of the head & neck has commenced.

New research brings personalized cancer vaccine approach one step closer to reality

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University School of Medicine in St. Louis has brought the approach one step closer to reality.

Zargis Medical receives FDA approval for marketing Signal X6 device

Zargis Medical Corp., a spin-off from Siemens Corporate Research and a majority-owned subsidiary of Speedus Corp., announced today it has received U.S. Food and Drug Administration (FDA) clearance to market its new Signal X6(TM) device.

Acetaminophen can prevent age-related problems

Recent studies conducted by Dr. Eric Blough and his colleagues at Marshall University have shown that use of the common pain reliever acetaminophen may help prevent age-associated muscle loss and other conditions.

Statin therapy should still be used first to reach blood cholesterol levels before considering niacin

Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. Cardiovascular atherosclerosis, as it is also known, is believed responsible for one in three deaths in the United States each year.

Wanda Roberton, MD - General Practice in Federal Way, WA